GLP1R and type 2 diabetes mellitus: Current guidelines recommend a multifaceted approach to type 2 DM (T2DM) management, including lifestyle modifications, oral anti-diabetic agents, and, if necessary, injectable therapies such as insulin or glucagon-like peptide-1 receptor agonists (GLP-1 RAs) [3].